Literature DB >> 30237052

Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.

Mohamed Mammeri1, Aurélie Chevillot2, Myriam Thomas2, Bruno Polack3, Christine Julien4, Jean-Philippe Marden4, Eric Auclair4, Isabelle Vallée2, Karim Tarik Adjou5.   

Abstract

Cryptosporidiosis is a zoonotic disease caused by species in the genus Cryptosporidium. In young ruminants, Cryptosporidium parvum causes economically significant disease with mild to severe clinical signs and occasional death. The typical clinical course in animals aged 1-3 weeks old is acute diarrhoea. Currently there are no available treatments that are fully effective against cryptosporidiosis in either humans or animals. Therefore there is a critical need for the development of new therapeutic agents. We adapted two in vitro culture systems (HCT-8 and Caco-2 cell lines) for C. parvum infection to investigate the "anticryptosporidial" activity of two chitosans; Chitosan NAG and Chitosan Mix. Chitosan-a naturally-occurring polysaccharide compound-has been found to be active against a variety of diseases, possessing both antimicrobial and anticancer properties. We investigated both chitosan's toxicity and effects on C. parvum in the two in vitro models. To evaluate chitosan's effects on oocyst shedding in vivo, CD-1 neonate mice were orally inoculated with C. parvum oocysts (Iowa strain), treated with chitosan, and compared to infected non-treated animals. Paromomycin, a classical drug used in veterinary medicine, was used as a reference compound. Immunofluorescence techniques were used to analyse the parasites. Our results showed significant reductions in Cryptosporidium oocyst viability (>95%) after oocyst pre-incubation with either paromomycin (P < 0.001), Chitosan Mix or Chitosan NAG (P < 0.001), for 24 h at 37 °C. Additionally, paromomycin, Chitosan Mix, and Chitosan NAG significantly inhibited C. parvum multiplication in HCT-8 and Caco-2 cell lines (P < 0.005). These effects were dose-dependent. In in vivo studies, treatment with both chitosans (Chitosan NAG, Chitosan Mix) or paromomycin sulfate significantly reduced parasite shedding in infected treated newborn mice (-56%, -34.5% and -58%, respectively). In conclusion, these findings provide the first in vitro and in vivo evidence of the anticryptosporidial activities of this natural polysaccharide.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD-1 neonate mice; Caco-2 cells; Chitosan; Cryptosporidiosis; Cryptosporidium parvum; HCT-8 cells; Paromomycin sulfate; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30237052     DOI: 10.1016/j.exppara.2018.09.003

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

1.  Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.

Authors:  Shahira A Ahmed; Heba S El-Mahallawy; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

2.  Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.

Authors:  Howayda Said Fouad Moawad; Mohamed Hegab Abd El-Hady Hegab; Maha Saber Reda Badawey; Shaimaa Elsayed Ashoush; Shereen Mahmoud Ibrahim; Amira Abd El-Lateef Saleh Ali
Journal:  J Parasit Dis       Date:  2021-01-06

Review 3.  Effect of chitosan on Toxoplasma gondii infection: A systematic review.

Authors:  Kourosh Cheraghipour; Leila Masoori; Fatemeh Ezzatkhah; Iraj Salimikia; Sana Amiri; Ali Safar Makenali; Farshad Taherpour; Hossein Mahmoudvand
Journal:  Parasite Epidemiol Control       Date:  2020-10-21

4.  Chitosan Protects Immunosuppressed Mice Against Cryptosporidium parvum Infection Through TLR4/STAT1 Signaling Pathways and Gut Microbiota Modulation.

Authors:  Sajid Ur Rahman; Haiyan Gong; Rongsheng Mi; Yan Huang; Xiangan Han; Zhaoguo Chen
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 5.  Antiparasitic Effects of Sulfated Polysaccharides from Marine Hydrobionts.

Authors:  Natalya N Besednova; Tatyana S Zaporozhets; Boris G Andryukov; Sergey P Kryzhanovsky; Svetlana P Ermakova; Tatyana A Kuznetsova; Anastasia N Voronova; Mikhail Y Shchelkanov
Journal:  Mar Drugs       Date:  2021-11-12       Impact factor: 5.118

6.  The determination of treatment effect of chitosan oligosaccharide in lambs with experimentally cryptosporidiosis.

Authors:  Ugur Aydogdu; Alparslan Coskun; Ahmet Duran Atas; Onur Basbug; Zahid Tevfik Agaoglu
Journal:  Small Rumin Res       Date:  2019-09-27       Impact factor: 1.611

7.  Molecular characterization of Cryptosporidium isolates from diarrheal dairy calves in France.

Authors:  Mohamed Mammeri; Aurélie Chevillot; Ilham Chenafi; Myriam Thomas; Christine Julien; Isabelle Vallée; Bruno Polack; Jérôme Follet; Karim Tarik Adjou
Journal:  Vet Parasitol Reg Stud Reports       Date:  2019-07-24

8.  Cryptosporidium parvum Infection Depletes Butyrate Producer Bacteria in Goat Kid Microbiome.

Authors:  Mohamed Mammeri; Dasiel Alvarez Obregón; Aurélie Chevillot; Bruno Polack; Christine Julien; Thomas Pollet; Alejandro Cabezas-Cruz; Karim Tarik Adjou
Journal:  Front Microbiol       Date:  2020-10-16       Impact factor: 5.640

Review 9.  Chitosan-Based Nanomaterials as Valuable Sources of Anti-Leishmanial Agents: A Systematic Review.

Authors:  Hamdan I AlMohammed; Amal Khudair Khalaf; Aishah E Albalawi; Abdullah D Alanazi; Parastoo Baharvand; Ali Moghaddam; Hossein Mahmoudvand
Journal:  Nanomaterials (Basel)       Date:  2021-03-10       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.